Company: SMNR
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001213900-25-044889
Chunk: 130

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 4
Chunk 130
---
Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls
and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15(b) and 15d-15 under
the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design
and operation of our disclosure controls and procedures as of March 31, 2025. Based upon their evaluation, our Chief Executive Officer
and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) were effective.

Changes in Internal Control over Financial
Reporting

During the quarter ended March 31, 2025, there
has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.

37

Part
II. OTHER INFORMATION

Item
1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

As of the date of this Quarterly Report, there
have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December
31, 2024 filed with the SEC on April 2, 2025 other than those set forth under "Risk Factors" in the Semnur Proxy Statement/Prospectus.

Item
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item
3. DEFAULTS UPON SENIOR SECURITIES.

None.

Item
4. MINE SAFETY DISCLOSURES.

Not applicable.

Item
5. OTHER INFORMATION.

None.

38

Item
6. EXHIBITS.

The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.

    No.